Target intelligence / Profile preview

Ribosomal protein S3a pseudogene 23 (RPS3AP23)

Target: RPS3AP23
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein S3a pseudogene 23 (RPS3AP23) is a transcribed processed pseudogene derived from the parental gene RPS3A, which encodes a component of the small 40S ribosomal subunit, but RPS3AP23 itself does not encode a functional protein. It is classified as a retrocopy located on chromosome 10 (chr10:83671400-83672259). As with most ribosomal protein pseudogenes, RPS3AP23 has no known biological function, no role in disease, and is not considered a therapeutic target[7][8][9][10].

Other names: RPS3AP23Ribosomal protein S3a pseudogene 23RPS3A_8_764

Beyond the preview

Go deeper on Ribosomal protein S3a pseudogene 23 (RPS3AP23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S3a pseudogene 23 (RPS3AP23).

Explore the full profile